SCHEMBL1172633

SCHEMBL1172633

NC(=O)c1cc(N)cc(CO)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
PRSS1 P07477 2/20 0.37
PRSS2 P07478 2/20 0.37
PRSS3 P35030 2/20 0.37
CYP3A4 P08684 2/20 0.35
PARP1 P09874 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ACHE P22303 1/20 0.34
PARP10 Q53GL7 3/20 0.34
PLA2G10 O15496 1/20 0.34
PLA2G2A P14555 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
PRKCA P17252 1/20 0.33
PRKCD Q05655 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4447450 0.87 PRSS1 (0.42) TSHRPRSS1PRSS2PRSS3CYP3A4
SCHEMBL6163099 0.87 PRSS1 (0.42) TSHRPRSS1PRSS2PRSS3CYP3A4
SCHEMBL7589533 0.83 TPMT (0.46) TSHRSMN1; SMN2ACHELMNAHTT
SCHEMBL3503704 0.83 TSHR (0.39) TSHRCYP3A4SMN1; SMN2PARP10PLA2G10
Hydrochloric Acid SCHEMBL7596506 0.82 TPMT (0.45) TSHRSMN1; SMN2ACHELMNAHTT
SCHEMBL1807992 0.79 KDM4E (0.46) TSHRCYP3A4PARP1SMN1; SMN2PARP10
SCHEMBL890399 0.79 CYP3A4 (0.44) TSHRCYP3A4PARP1SMN1; SMN2PARP10
SCHEMBL20194145 0.79 PRSS1 (0.55) PRSS1PRSS2PRSS3ACHE
SCHEMBL5898518 0.79 PARP10 (0.49) TSHRPRSS1PRSS2PRSS3CYP3A4
SCHEMBL3488223 0.78 ADRA1D (0.50) TSHRPRSS1PRSS2PRSS3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046108-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2011-02-24 US disclosed
US-20110046108-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2011-02-24 US disclosed
US-20110046108-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2011-02-24 US disclosed
WO-2007085833-A2 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046108-A1 PYRIMIDINE DERIVATIVES EPHB4, EPHB1, EPHB3 TSHR 2112/4885PRSS1 1719/4885PRSS2 2689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.